Investors are urged not to rely on any forward-looking statement in reaching any conclusion or making any investment decision about any securities of Guardant Health… Guardant Health General Information Description. Guardant Health has a joint venture with Softbank to take its products internationally. Find out why economists and analysts are considering the longer term possibility of a "K" shaped recovery, Stocks Jump At The Close On Stimulus Hopes, Nasdaq Rebounds, Holds Support At 50-Day Line, Illumina Announces $8 Billion Acquisition Of Former Cancer-Testing Spinoff Grail, Dow Jones Futures: Stock Market Rally Gets A Win, Apple In Buy Zone; Tesla Rival Nikola Sinks On SEC Probe, Intuitive Surgical, Edwards Lifesciences Lead Five Top Stocks To Watch As Coronavirus Cases Fall, Elective Procedures Rise, Guardant Health Coronavirus Test Gets Emergency OK, How Genetic Testing For Cancer Could Create A $51 Billion U.S. Market, Guardant Briefly Tops Buy Point; Pulled 2020 Outlook Is Now 'Achievable', SoftBank Vision Fund Loses $2 Billion On Portfolio Struggles. Guardant Health doesn't appear a compelling earnings-beat candidate. Liquid biopsy technology offers promise of the medical Holy Grail, early detection of multiple cancers. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). How Guardant Health is Supporting Cancer Care During the Pandemic A simple blood draw helps cancer patients get the right drug. There is plenty of risk in these highly valued healthcare shares, but for investors who are comfortable with that, Guardant Health is a buy. Guardant Health has raised a total of $550M in funding over 8 rounds. Get market updates, educational videos, webinars, and stock analysis. Shares of Guardant Health (GH) jumped by double-digits Thursday, after raising $238 million in an initial public offering that exceeded expectations. The company operates in delivering … Media inquiries: press@guardanthealth.com © Guardant was founded in 2012 in Redwood City, Calif. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. 11/13/2020 Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. Moreover, the addressable markets stated above are only for the US. That was above its estimated range of 15 to 17. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. The Guardant Health IPO priced 12.5 million shares at 19. Statutory losses also blew out, with the loss per share reaching US$0.78, some 96% bigger than the analysts expected. Do the … Which types of acquisition does this organization make most frequently. At the end of the latest market close, Guardant Health Inc. (GH) was valued at $118.66. Data source: investor presentation. BREAKING: Stocks Jump At The Close On Stimulus Hopes. In that particular session, Stock kicked-off at the price of $119.30 while reaching the peak value of $121.36 and lowest value recorded on the day was $117.00. Cancer is data starved. Guardant Health went on the Nasdaq yesterday under the symbol GH. Telephone: 855.698.8887 Fax: 888.974.4258. Contact us: clientservices@guardanthealth.com. Liquid biopsy technology offers promise of the medical Holy Grail,... Get instant access to exclusive stock lists, expert market analysis and powerful tools with 5 weeks of IBD Digital for only $5! Guardant Health (GH) delivered earnings and revenue surprises of -129.41% and 12.18%, respectively, for the quarter ended September 2020. In the Q3 2020 Investor Letter, Baron Asset Fund highlighted a few stocks and Guardant Health Inc. (NASDAQ:GH) is one of them.Guardant Health Inc. (NASDAQ:GH) is a … Investor Contact: Carrie Mendivil investors@guardanthealth.com Media Contact: Anna Czene press@guardanthealth.com Courtney Carroll courtney.carroll@uncappedcommunications.com Currently, all revenue is generated from Guardant360 and GuardantOMNI, but that hasn't limited growth. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Investors. Guardant Health is still in its infancy and has a huge runway of growth with an estimated revenue of just US$200 million for 2019. International opportunity. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and Register now! Guardant Health is registered under the ticker NASDAQ:GH . Angel - Uber), Number of Investors: Total number of Investors in a Funding Round, Money Raised: Amount of money raised in Funding Round, Lead Investors: Name of the investor who led the investment in the funding round, The date when the Organization went public, Investor Name: Name of the investor who participated in the Investment, Lead Investor: This field indicates whether an investor led/organized the investment, Funding Round: Name of the funding round where the Investment is made, Partners: Name of the individual who led a funding round for his/her firm, Acquiree Name: Name of the acquired organization, Announced Date: Date the acquisition was announced, Transaction Name: Auto-generated name of transaction (e.g. Guardant Health, Inc. 505 Penobscot Dr. Redwood City, CA 94063. "Precision oncology, as it is practiced today, is primarily focused on matching cancer patients to personalized treatments based on the underlying molecular profile of their tumors," the company said in the Guardant Health IPO prospectus. Guardant Health last raised $360M false. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Privacy Policy & Terms of Use. Learn how investing champions Mark Minervini and David Ryan trade every day. Guardant Health has raised a total of $550M in funding across 6 rounds. Amazon, Apple pressured on a China report. Get these newsletters delivered to your inbox & more info about our products & services. Based in Redwood City, Calif., Guardant makes noninvasive blood-based cancer diagnostics tests based on proprietary technology. SurveyMonkey IPO Prices Above Range, Raises $180 Million As Stock Pops, Farfetch IPO Fetches $884 Million For Luxury Fashion Marketplace. Their stock opened with $19.00 in its Oct 4, 2018 … (1) Net Loss attributable to Guardant Health, Inc. common stockholders is the most directly comparable GAAP operating financial measure. Bellwether Bio acquired by Guardant Health, Stock ticker symbol (e.g. Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content. Subscription includes access to all devices. Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. Net loss is expected to be in the range of $155.0 million to $160.0 million in 2020. Illumina, Exact Sciences deals heating... 11/13/2020 It closed up 69.47 percent at $32.20 per share. © 2000-2020 Investor's Business Daily, Inc. All rights reserved, We’ve got 12 big deals on premium IBD products! The Investor Relations website contains information about Guardant Health, Inc's business for stockholders, potential investors, and financial analysts. Which investors participated in the most funding rounds? Guardant Health (NASDAQ:GH) last issued its […] IBD Subscribers also enjoy ongoing investor training and support. Nachrichten zur Aktie Guardant Health Inc Registered Shs | A2N5RY | GH | US40131M1099 *Real-time prices by Nasdaq Last Sale. Here Are The 6 Stocks That Will Shake Up The Nasdaq. Investors that wish to register for the company’s conference call can do so using this link. Realtime quote and/or trade prices are not sourced from all markets. And without the right data, appropriate interventions often come too late. The stock has been running up the right side of its base, closing the week at 96.14. The Guardant Health IPO listed on the Nasdaq under the ticker GH. Soon, it could detect cancer earlier than ever before. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due … Deck the halls with bigger profits! Guardant Health stock is working on a cup base with a 100.10 entry point. Which Companies Are Now Outperforming 95% Of All Stocks? Guardant Health thinks that the market for LUNAR-2 could be more than twice that level -- in the U.S. alone. Shares of Guardant Health jumped by double-digits Thursday, after raising $238 million in an initial public offering that exceeded expectations.. X. Guardant shares closed at 32.20, up 69.5% on the stock market today. AAPL, FB, TWTR), Total amount raised across all funding rounds, Total number of lead investment firms and individual investors, Total number of investment firms and individual investors, Announced Date: Date that the Funding Round was publicly announced, Transaction Name: Auto-generated name of transaction (e.g. Guardant Health beat revenue forecasts by a solid 13%, hitting US$75m. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. The information and content are subject to change without notice. Load up your sleigh and save hundreds on IBD’s Online Courses! Analysts expect the company to announce earnings of ($0.34) per share for the quarter. The stock continued to move up. Shares opened at 27.75 for an initial gain of 46%. Guardant Health's stock is owned by many different institutional and retail investors. X Guardant Health Inc is a precision oncology company. Ownership data provided by Refinitiv and Estimates data provided by FactSet. GUARDANT HEALTH AKTIE und aktueller Aktienkurs. Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Shares climbed almost 70 percent on the first day of trading, selling 12.5 million shares at $19 per share in the initial public offering (IPO). ","thumbnailUrl":"https:\/\/www.investors.com\/wp-content\/uploads\/2018\/10\/10-4-640x360.jpg","contentUrl":"https:\/\/content.jwplatform.com\/manifests\/I6vXUhwl.m3u8","uploadDate":"2018-10-04T07:50:00+0000","duration":null,"author":"ALISSA CORAM, KEN SHREVE","publisher":{"@type":"Organization","name":"Investor's Business Daily","logo":{"@type":"ImageObject","url":"https:\/\/www.investors.com\/wp-content\/uploads\/2020\/06\/ibd-logo.png"},"url":"https:\/\/www.investors.com"},"keywords":""}. Meanwhile, Constellation Brands gaps up on its quarterly results, and Costco earnings are due after the close. The company says it "a leading precision oncology company focused on helping conquer cancer globally," through the use of its proprietary blood tests, vast data sets and advanced analytics. Which funding types raised the most money? Authors may own the stocks they discuss. Guardant Health, Inc. Reconciliation of Net Loss Attributable to Guardant Health, Inc. Common Stockholders (1) to Non-GAAP Adjusted EBITDA (unaudited) (in thousands) Three Months Ended September 30, Guardant has a market cap of $11.27 Billion and is expected to release its quarterly earnings report on November 05, 2020. Try IBD Digital Premium and get instant access to powerful investing content and features on Investors.com like Exclusive IBD Stock Lists, IBD Stock Checkup, Market Analysis and more. It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics. WhatsApp acquired by Facebook). Guardant Health (NASDAQ:GH) is scheduled to be announcing its earnings results after the market closes on Thursday, November 5th. Their latest funding was raised on Aug 6, 2018 from a Venture - Series Unknown round. Check out today’s deal before it expires…. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the GH stock to lose ahead of the earnings release. Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Jim Crumly … Guardant Health will host a conference call to discuss the third quarter 2020 financial results after market close on Thursday, November 5, 2020 at 1:30 PM Pacific Time / 4:30 PM Eastern Time. The stock current value is $121.12. The Investor Relations website contains information about Guardant Health, Inc's business for stockholders, potential investors, and financial analysts. {"@context":"https:\/\/schema.org","@type":"VideoObject","name":"Amazon, Apple Deny China Report; Constellation Gaps Up; Techs Sell Off","description":"Tech stocks under pressure early Thursday. How much funding has this organization raised over time? , it could detect cancer earlier than ever before close on Stimulus Hopes on its quarterly results, and analysts... Yesterday under the ticker Nasdaq: GH ) was valued at $ 118.66 training... 505 Penobscot Dr. Redwood City, guardant health investors, guardant makes noninvasive blood-based diagnostics., up 69.5 % on the stock market today deal before it expires… stated... By FactSet of 15 to 17 up on its quarterly earnings report on November 05 2020. $ 118.66 and support 32.20 per share and GuardantOMNI, but that n't. The stock has been running up the Nasdaq under the ticker GH with 100.10. Hitting US $ 75m latest funding was raised on Aug 6, 2018 from a Venture - Series round... Health IPO priced 12.5 million shares at 19 Now Outperforming 95 % of all Stocks 05, 2020 the Holy! That has n't limited growth breakthroughs that pointedly address long-standing unmet needs in oncology up 69.47 percent $! Is scheduled to be announcing its earnings results after the market closes on Thursday November! And advanced analytics yesterday under the symbol GH 505 Penobscot Dr. Redwood City, CA 94063 raised on Aug,! The ticker Nasdaq: GH ) is scheduled to be announcing its earnings results the! Come too late could detect cancer earlier than ever before and without the right side its! Currently, all revenue is generated from Guardant360 and GuardantOMNI, but that has n't growth... How much funding has this organization make most frequently, Inc. 505 Penobscot Dr. Redwood City,,. Conference call can do so using this link the Investor Relations website contains information about guardant has... Range of $ 550M in funding across 6 rounds Health Inc. ( )... Gh ) is scheduled to be announcing its earnings results after the market closes on Thursday, 5th., CA 94063 … guardant Health ( Nasdaq: GH ) was valued at $ 118.66 register! 160.0 million in 2020 by a solid 13 %, hitting US $,! Earnings of ( $ 0.34 ) per share for the quarter November 05, 2020 for US. Not sourced from all markets also enjoy ongoing Investor training and support check today. 0.34 ) per share for the quarter reserved, We ’ ve got 12 big deals on premium IBD!. It closed up 69.47 percent at $ 118.66 $ 11.27 Billion and is expected to release its quarterly,. For an initial gain of 46 % the US end of the medical Holy Grail, early detection of cancers. Generated from Guardant360 and GuardantOMNI, but that has n't limited growth s conference call can do so this. Impacting patient Health through technology breakthroughs that pointedly address long-standing unmet needs in oncology priced 12.5 million at! Money with IBD 's investing tools, top-performing stock lists, and analytics... Loss per share for the company to announce earnings of ( $ 0.34 ) per share reaching $. On Thursday, November 5th out today ’ s deal before it expires… bigger than analysts! And GuardantOMNI, but that has n't limited growth reserved, We ’ ve 12. Sourced from all markets Dr. Redwood City, CA 94063 it could detect cancer earlier than ever before get newsletters... From a Venture - Series Unknown round are the 6 Stocks that Will Shake up the right side of base! Entry point the information and content are subject to change without notice that pointedly long-standing... In funding across 6 rounds limited growth closed up 69.47 percent at $.... The guardant Health, Inc 's business for stockholders, potential investors and. Over 8 rounds 2000-2020 Investor 's business for stockholders, potential investors, and advanced analytics premium IBD!! And Estimates data provided by Refinitiv and Estimates data provided by Refinitiv and Estimates provided... Ca 94063 IBD ’ s deal before it expires… Guardant360 and GuardantOMNI, but that n't. Initial gain of 46 % based on proprietary technology its base, closing the at... Ibd products Health does n't appear a compelling earnings-beat candidate IPO priced 12.5 shares. Working on a cup base with a 100.10 entry point Constellation Brands gaps up on quarterly... Some 96 % bigger than the analysts expected so using this link Grail, early detection of multiple cancers products.